搜尋結果
US FDA extends review of Ascendis Pharma's hormone disorder therapy
Reuters· 7 小時前, opens new tab therapy to treat adult patients with a hormone disorder by three months, the ...
Despite Lower Out-Of-Pocket Costs, Insulin Affordability Is Still A Critical Issue
Forbes· 3 日前In describing the financial burden caused by the high price of insulin products, a Fortune ...